ALVOTECH USA INC
BiotechALVOTECH USA INC is a biotechnology company focused on Immunology, Gastroenterology.
ALVOTECH USA INC's Key Drugs
ALVOTECH USA INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ALVOTECH USA INC's Recent FDA Approvals
New NDA/BLA approvals for ALVOTECH USA INC over the last two years — novel drugs only, excluding generics and label supplements.
ALVOTECH USA INC's Therapeutic Areas
ALVOTECH USA INC's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ALVOTECH USA INC's Top Competitors
ALVOTECH USA INC's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ALVOTECH USA INC Pipeline Snapshot
Active clinical trials for ALVOTECH USA INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2024-02-23
- Latest
- 2025-12-01
- Applications
- 2